"Very lucrative" is relative - but still a few years away.
$12 million is good ... but it will be greatly overshadowed by earnings from QFT for Tuberculosis. We are only just starting to see the earnings flow.
Although CST profit after tax last half was about $3.2m - that was a quarter that had H1N1 flu impact and the negative impact of missing the Japan uptake.
We should see that come through this half....
CST made $8.2m profit after tax last financial year...made up of $2.85m the first half and $5.35m the second half.
So the question is whether CST will issue profit guidance next month.
CST Price at posting:
$3.02 Sentiment: Buy Disclosure: Held
